Multilineage differentiation from human embryonic stem cell lines

Stem Cells

Volumn 19, Issue 3, 2001, Pages 193-204

  Odorico, Jon S ^a,c   Kaufman, Dan S ^a   Thomson, James A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Differentiation; Embryonic stem cells; Human; Pluripotent; Transplantation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; CELL DIFFERENTIATION; CELL TYPE; DIABETES MELLITUS; GRAFT REJECTION; HEART FAILURE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PARKINSON DISEASE; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0034983625     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-3-193     Document Type: Review

References (84)

1. Out of Eden: Stem cells and their niches
2. Embryonic stem cells alone are able to support fetal development in the mouse
3. Formation of germline chimaeras from embryo-derived teratocarcinoma cell lines
4. Establishment in culture of pluripotent cells from mouse embryos
5. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
6. Isolation of a primate embryonic stem cell line
7. Embryonic stem cell lines derived from human blastocysts
8. Isolation and culture of inner cell mass cells from human blastocysts
9. The origin and efficient derivation of embryonic stem cells in the mouse
10. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro
11. Derivation of pluripotent stem cells from cultured human primordial germ cells
12. A comparative study of eight cell lines derived from human testicular teratocarcinoma
13. Normal genetically mosaic mice produced from malignant teratocarcinoma cells
14. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture
15. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture
16. Primate embryonic stem cells
17. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro
18. Specific association of human telomerase activity with immortal cells and cancer
19. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow
20. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow
21. Telomerase activity and telomere detection during early bovine development
22. Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos
23. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers
24. Properties and uses of embryonic stem cells: Prospects for application to human biology and gene therapy
25. The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium
26. Embryonic stem cells and in vitro muscle development
27. In vitro differentiation of embryonic stem cells
28. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: Developmentally regulated expression of myogenic determination genes and functional expression of ionic currents
29. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: A retinoic acid and db-cAMP in vitro differentiation model
30. Embryonic stem cell-derived adipogenesis
31. Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic, or adipogenic pathways
32. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies
33. Derivation of melanocytes from embryonic stem cells in culture
34. Embryonic stem cell-derived glial precursors: A source of myelinating transplants
35. Embryonic stem cells express neuronal properties in vitro
36. Neuronal progenitors as tools for cell replacement in the nervous system
37. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice
38. Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies
39. Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders
40. Embryonic stem cells as a model for studying regulation of cellular differentiation
41. Regulation of a transcription factor network required for differentiation and metabolism
42. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells
43. Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination
44. Efficient poly A trap approach allows the capture of genes specifically active in differentiated embryonic stem cells and in mouse embryos
45. Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes
46. In vitro preselection of gene-trapped embryonic stem cell clones for characterizing novel developmentally regulated genes in the mouse
47. Directed differentiation of human embryonic stem cells into hematopoietic colony forming cells
48. Differentiation of endoderm derivatives, pancreas and intestine, from rhesus embryonic stem cells
49. In vitro cultivation of human islets from expanded ductal tissue
50. Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells
51. Pancreatic and duodenal homeobox gene I induces expression of insulin genes in liver and ameliorates streptzotocin-induced hyperglycemia
52. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts
53. Generation of purified neural precursors from embryonic stem cells by lineage selection
54. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype
55. Stem cells: Units of development, units of regeneration, and units in evolution
56. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord
57. Transplant-ability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
58. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction
59. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats
60. Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats
61. Grafted cerebellar cells in a mouse model of hereditary ataxia express IGF-I system genes and partially restore behavioral function
62. Fetal rat hepatocytes: Isolation, characterization, and transplantation in the Nagase analbuminemic rats
63. Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure
64. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro
65. FACS for the isolation of individual cells from transgenic mice harboring a fluorescent protein reporter
66. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model
67. + channel blockers
68. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro
69. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine
70. Streptozotocin diabetes in the monkey: Plasma levels of glucose, insulin, glucagon, and somatostatin, with corresponding morphometric analysis of islet endocrine cells
71. In vitro-generated neural precursors participate in mammalian brain development
72. Transplantation therapies from human embryonic stem cells - Circumventing immune rejection
73. Mice lacking major histocompatibility complex class I and class II molecules
74. Transposon -generated 'knock-out' and 'knock-in' gene-targeting constructs for use in mice
75. Lymphocyte development. The (knock) ins and outs of lymphoid development
76. The future of organ and tissue transplantation: Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?
77. Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back
78. Major histocompatibility complex restriction and transplantation immunity. A possible solution to the allograft problem
79. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection
80. From cows stem therapies?
81. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism
82. Renal transplantation for end-stage renal disease following bone marrow transplantation: A report of six cases, with and without immunosuppression
83. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning